News & Publications

We are pleased to announce that Peter J. Roberts was recently appointed Queen’s Counsel. These appointments recognize exceptional merit and contribution to the legal profession and are available to only 7% of legal practitioners. Congratulations Peter!

This paper discusses contract law issues including decisions of relevance to commercial lawyers and business leaders giving a snapshot of particular principles of interest that arose in case law over the past 12 months.

Angela Austman quoted in Business in Vancouver article, "Networking not just small talk, experts tell aspiring entrepreneurs"

We are pleased to announce that 50 of Lawson Lundell LLP’s lawyers have been recognized in the 13th Edition of The Best Lawyers in Canada® across 33 practice areas.

Rita Andreone, QC and Chat Ortved prepared a Q&A guide to "Corporate Governance and Directors' Duties in Canada: Overview." The Q&A gives a high level overview of board composition, the comply or explain approach, management rules and authority, directors’ duties and liabilities, transactions with directors and conflicts, company meetings, internal controls, accounts and audit, institutional investors and reform proposals.

Nicole Skuggedal and Katy Allen's article, "Class Action for Workplace Sexual Harassment Allowed to Proceed" was featured in Canadian HR Reporter's newsletter section, Canadian Employment Law Today.

Craig Ferris, QC, FCIArb. was quoted in a recent article in The Lawyer's Daily, "B.C. modernizes class action legislation; group looking into same for Ontario." This article discusses British Columbia's changes to modernize its legislation on class action proceedings and examines how this may lead to an increase in class actions.

Read the full article here.

On Thursday, April 12, 2018, Arbutus Biopharma Corporation (“Arbutus”), an industry-leading hepatitis B virus (HBV) therapeutic solutions company and Roivant Sciences Ltd. (“Roivant”) announced that they have entered into an agreement to launch Genevant Sciences (“Genevant”), a jointly-owned company focused on the discovery, development, and commercialization of a broad range of RNA-based therapeutics.

Craig Ferris, Q.C.,FCIArb has written a new Commercial Litigation and Dispute Resolution Blog post entitled, "Transactional Common Interest Privilege Recognized by the Federal Court of Appeal" discussing the Federal Court of Appeal’s recent decision on common interest privilege in a transactional context.

This paper discusses contract law issues including decisions of relevance to commercial lawyers and business leaders giving a snapshot of particular principles of interest that arose in case law over the past 12 months.